INFLAMMA DRY— 510(k) K132066

Substantially Equivalent

Rapid Pathogen Screening, Inc.

FDA 510(k) clearance K132066 for INFLAMMA DRY, Substantially Equivalent on 2013-11-21. Applicant: Rapid Pathogen Screening, Inc..

Clearance details

Applicant: Rapid Pathogen Screening, Inc.
Product code: Code PFQ
Advisory panel: Clinical Chemistry
Date received: 2013-07-03
Decision date: 2013-11-21
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Sarasota, FL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.